| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. | J Clin Microbiol | 2009 | 1.07 |
| 2 | The need for standardization of tacrolimus assays. | Clin Chem | 2011 | 1.04 |
| 3 | Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. | Ther Drug Monit | 2009 | 0.99 |
| 4 | Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay. | Ther Drug Monit | 2010 | 0.84 |
| 5 | Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer. | Clin Biochem | 2009 | 0.80 |
| 6 | Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood. | Transfusion | 2008 | 0.75 |